What the Polio Case in New York Tells Us About the End of Polio
The Rockland County case isn鈥檛 expected to cause a major outbreak, but it shows how even this rare disease can pop up in undervaccinated communities.
Vaccines
281 - 300 of 827 Results
-
-
KHN鈥檚 鈥榃hat the Health?鈥: Manchin Makes a Deal
In a rare surprise for official Washington, Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D-W.Va.) announced a deal to expand the planned health bill in the Senate to include provisions raising taxes and addressing climate change. The measure would include a third year of expanded subsidies for the Affordable Care Act, but not health care coverage for people left out of Medicaid in states that failed to expand the program. Meanwhile, the ACA goes back to court, and the Biden administration restores anti-discrimination protections for LGBTQ+ people that were rolled back by the Trump administration. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. C茅line Gounder of KHN about the latest on the monkeypox outbreak.
-
-
Boost Now or Wait? Many Wonder How Best to Ride Out Covid鈥檚 Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven't received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren鈥檛 sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
By Sam Whitehead and Arthur Allen -
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.
-
Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
-
‘Free’ Screening? Know Your Rights to Get No-Cost Care
Even a decade in, the Affordable Care Act鈥檚 recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
-
鈥楳y Body, My Choice鈥: How Vaccine Foes Co-Opted the Abortion Rallying Cry
Anti-vaccine advocates discovered a catchy, succinct, and potent slogan. Its unlikely source: the abortion rights movement.
By Rachel Bluth -
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government鈥檚 covid-fighting strategy.
By Arthur Allen -
KHN鈥檚 鈥榃hat the Health?鈥: A World Without 鈥楻oe鈥
The Supreme Court鈥檚 decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Angela Hart, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about two identical eye surgeries with very different price tags.
-
What You Need to Know About Monkeypox
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here鈥檚 what everyone should know about it.
-
Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles
KHN gives readers a chance to comment on a recent batch of stories.
-
KHN鈥檚 鈥榃hat the Health?鈥: Closing In on Covid Vaccines for 鈥楾he Littles鈥
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Perspective
Will the US Overcome Its Covid Complacency Even as the Threat Returns?
One million Americans have died from covid-19 鈥 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation鈥檚 pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
-
Journalists Delve Into Vaccine Mandates and Surprise Billing
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
Readers and Tweeters Go to the Mat on Abortion Rights and Perceived Wrongs
KHN gives readers a chance to comment on a recent batch of stories.
-
Politics and Pandemic Fatigue Doom California鈥檚 Covid Vaccine Mandates
Even in deep-blue California, Democratic lawmakers pulled their proposed covid vaccine requirements before they had a vote. The lawmakers blamed the ebbs and flows of the coronavirus, the public鈥檚 short attention span, and opposition from public safety unions.
By Rachel Bluth -
KHN Spotlight
Watch: UVA Doctor Talks About the State of the Pandemic and Health Equity聽
KHN checks back in with Dr. Taison Bell to pinpoint changes in health care equity since the rollout of the covid-19 vaccines.
-
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
By Arthur Allen and Sarah Jane Tribble -
Watch: Going Beyond the Script of 鈥楾he G Word鈥 and How Government Responds to Disease (Or Not)
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, 鈥淭he G Word,鈥 which examines the federal government's role in Americans' lives, and how it plays out in the covid era.